Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 1048 entries
View as:

Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02618356 Org: User:
Start: 12/25/15 End: 11/30/17 Due: 11/30/18

HPV Genotype Attribution and Disease Burden of Anal Cancer in China

Phase: N/A Priority: Normal
NCT ID: NCT06670495 Org: User:
Start: 01/01/25 End: 12/31/28 Due: 12/31/29

An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2)

Phase: N/A Priority: Normal
NCT ID: NCT05928780 Org: User:
Start: 07/01/23 End: 09/01/25 Due: 09/01/26

Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC

Phase: N/A Priority: Normal
NCT ID: NCT00767377 Org: User:
Start: 05/31/07 End: 03/31/13 Due: 03/31/14

Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04745975 Org: User:
Start: 02/01/21 End: 01/31/23 Due: 01/31/24

Clinical Study of Imaging Genomics Based on Machine Learning for BCIG

Phase: N/A Priority: Normal
NCT ID: NCT04461990 Org: User:
Start: 12/01/20 End: 12/30/23 Due: 12/30/24

Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Quality of Life in Patients Undergoing Total Gastrectomy

Phase: N/A Priority: Normal
NCT ID: NCT01697943 Org: User:
Start: 05/31/12 End: 05/31/17 Due: 05/31/18

A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05660213 Org: User:
Start: 08/31/25 End: 08/31/30 Due: 08/31/31

Wound Management Following Gl Tumor Surgery: Comparing Outcomes of Dressing Changes Versus Non-Dressing Techniques

Phase: N/A Priority: Normal
NCT ID: NCT06263205 Org: User:
Start: 04/01/24 End: 12/24/26 Due: 12/24/27

X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT03753685 Org: User:
Start: 12/31/18 End: 10/31/20 Due: 10/31/21

Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06525428 Org: User:
Start: 04/01/24 End: 12/31/27 Due: 12/31/28

Predicting Response to Chemotherapy in Colorectal Cancer Via Multi-dimensional Analyses of the Tumor Associated Neutrophils

Phase: N/A Priority: Normal
NCT ID: NCT06495827 Org: User:
Start: 07/31/10 End: 08/31/23 Due: 08/31/24

AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06494995 Org: User:
Start: 07/03/24 End: 07/01/28 Due: 07/01/29

Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT06718933 Org: User:
Start: 01/08/25 End: 02/28/27 Due: 02/28/28

POLA-R-CHP in the First-line Treatment of Transformed DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT06743945 Org: User:
Start: 02/17/25 End: 12/31/29 Due: 12/31/30

Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE

Phase: N/A Priority: Normal
NCT ID: NCT01895010 Org: User:
Start: 06/30/13 End: 12/31/14 Due: 12/31/15

Short-term Cardiovascular Benefits of Wearing Particulate-filtering Respirators

Phase: N/A Priority: Normal
NCT ID: NCT02238028 Org: User:
Start: 03/31/14 End: 12/31/14 Due: 12/31/15

The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03403101 Org: User:
Start: 07/01/20 End: 07/01/24 Due: 07/01/25

Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06914687 Org: User:
Start: 03/30/25 End: 04/01/28 Due: 04/01/29

Effects of Docosahexanoic Acid on Neurocognitive Impairment in HIV-infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT04242004 Org: User:
Start: 10/30/19 End: 05/01/20 Due: 05/01/21

Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06355037 Org: User:
Start: 05/20/24 End: 01/31/25 Due: 01/31/26

Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas

Phase: N/A Priority: Normal
NCT ID: NCT06914674 Org: User:
Start: 03/20/25 End: 02/28/28 Due: 02/28/29

Predicting Gastric Neoplasia in Patients with High-risk Endoscopic Features

Phase: N/A Priority: Normal
NCT ID: NCT06853509 Org: User:
Start: 03/01/25 End: 12/31/33 Due: 12/31/34

Toripalimab in the Neoadjuvant Treatment of BRAF V600 Wild Type Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT04248387 Org: User:
Start: 06/17/19 End: 04/30/22 Due: 04/30/23

Acute Effects of Low Temperature Exposure on Respiratory System

Phase: N/A Priority: Normal
NCT ID: NCT06652932 Org: User:
Start: 10/16/24 End: 12/31/26 Due: 12/31/27